Preclinical Assessment of Investigational Cellular and Gene Therapy Products: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 1, 2013
February 3, 2025
e4aedc4e-81e3-4d2e-b655-2460ccf3a04e
Related Documents
Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Guidance for Industry
Guidance DocumentDecember 1, 2011Center for Biologics Evaluation and Research
Clinical Considerations for Therapeutic Cancer Vaccines: Guidance for Industry
Guidance DocumentOctober 1, 2011Center for Biologics Evaluation and Research
Potency Tests for Cellular and Gene Therapy Products: Final Guidance for Industry:
Guidance DocumentJanuary 1, 2011Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.